Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/2509 stock hub

HKG/2509 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2509is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.8B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2509

In the news

Latest news · HKG/2509

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.7

P25 11.7P50 18.9P75 41.4

Trailing P/E10.7

P25 10.7P50 17.9P75 38.5

ROE68.3

P25 -14.7P50 2P75 9.4

ROIC20.6

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2509 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

188

Groups with data

Currency

CNY

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	HK
Employees	337
Employees Change	-2%
Employees Change Percent	-0.59
Enterprise value	HKD 3.2B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE1000069W9
Last refreshed	2026-05-10
Market cap	HKD 3.8B
Price	HKD 16.7
Price currency	HKD
Rev Per Employee	2,664,672.02x
Sector	Healthcare
Sic	2836
Symbol	hkg/2509
Website	https://www.qyuns.net

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.33%
EV Earnings	9.2x
EV/EBIT	8.76x
EV/EBITDA	7.99x
EV/FCF	7.37x
EV/Sales	3.58x
FCF yield	11.64%
Forward P/E	16.67x
P/B ratio	4.96x
P/E ratio	10.68x
P/S ratio	4.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	40.91%
EBITDA Margin	44.69%
FCF margin	48.62%
Gross margin	88.53%
Gross Profit	HKD 795M
Gross Profit Growth	207.86%
Gross Profit Growth Q	886.08%
Gross Profit Growth3 Y	166.47%
Gross Profit Growth5 Y	136.47%
Net Income	HKD 349.9M
Net Income Growth Quarters	6%
Net Income Growth Years	2%
Pretax Margin	38.09%
Profit Margin	38.97%
Profit Per Employee	HKD 1M
Profitable Years	1
ROA	15.97
ROCE	30.11
ROE	68.31
ROIC	20.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	46.79%
EPS Growth Quarters	6
EPS Growth Years	2
Revenue Growth	408.18x
Revenue Growth Q	427.32x
Revenue Growth Quarters	5x
Revenue Growth Years	3x
Revenue Growth3 Y	161.9x
Revenue Growth5 Y	142.3x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.62
Assets	HKD 1.8B
Cash	HKD 1.2B
Current Assets	HKD 1.3B
Current Liabilities	HKD 580.1M
Debt	HKD 645.4M
Debt EBITDA	HKD 1.6
Debt Equity	HKD 0.85
Debt FCF	HKD 1.48
Equity	HKD 755.7M
Interest Coverage	17.17
Liabilities	HKD 1B
Long Term Assets	HKD 494.9M
Long Term Liabilities	HKD 445.1M
Net Cash	HKD 514.8M
Net Cash By Market Cap	HKD 13.73
Net Cash Growth	1,497.61%
Net Debt EBITDA	HKD -1.28
Net Debt Equity	HKD -0.68
Net Debt FCF	HKD -1.18
Tangible Book Value	HKD 769.6M
Tangible Book Value Per Share	HKD 3.41
WACC	10.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.22
Inventory Turnover	15.7
Net Working Capital	HKD -278.7M
Quick ratio	2.11
Working Capital	HKD 682.1M
Working Capital Turnover	HKD 2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	46.75%
200-day SMA	21.93
50-day SMA	18.41
50-day SMA vs 200-day SMA	50under200
All Time High	36.5
All Time High Change	-54.25%
All Time High Date	2025-10-02
All Time Low	5.95
All Time Low Change	180.67%
All Time Low Date	2025-02-05
ATR	1.11
Beta	1.44
Beta1y	1.03
Beta2y	1.25
Ch YTD	-11.08
High	17.06
High52	36.5
High52 Date	2025-10-02
High52ch	-54.25%
Low	16.6
Low52	10.8
Low52 Date	2025-05-16
Low52ch	54.63%
Ma50ch	-9.29%
Price vs 200-day SMA	-23.85%
RSI	36.63
RSI Monthly	45.69
RSI Weekly	41.39
Sharpe ratio	0.87x
Sortino ratio	1.44
Total Return	-1.94%
Tr YTD	-11.08
Tr1m	-16%
Tr1w	-6.34%
Tr3m	-14.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 367.4M
Operating margin	40.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	106,775,600%
Net Borrowing	59,183,431.5
Shares Insiders	4.45%
Shares Institutions	14.14%
Shares Out	224,567,600
Shares Qo Q	1.46%
Shares Yo Y	1.94%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 382.4M
Average Volume	396,763.5x
Bv Per Share	3.42
CAPEX	HKD -8.3M
Ch1m	-16
Ch1w	-6.34
Ch1y	46.75
Ch3m	-14.58
Ch6m	-13.25
Change	-1.88%
Change From Open	-1.82
Close	17.02
Days Gap	-0.06
Depreciation Amortization	35,131,885.6
Dollar Volume	4,452,220
Earnings Date	2026-03-27
EBIT	HKD 367.4M
EBITDA	HKD 401.3M
EPS	HKD 1.56
F Score	8
FCF	HKD 436.6M
FCF EV Yield	13.56x
FCF Per Share	HKD 1.94
Financing CF	104,300,366
Fiscal Year End	December
Founded	2,015
Graham Number	10.97787
Graham Upside	-34.26
Income Tax	HKD -81,235
Investing CF	132,078,336
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Ma150	21.3
Ma150ch	-21.58%
Ma20	18.68
Ma20ch	-10.6%
Net CF	668,865,728
Open	17.01
P FCF Ratio	8.59
P OCF Ratio	8.43
Position In Range	21.74
Ppne	356,783,022.4
Price Date	2026-05-08
Price EBITDA	HKD 9.34
Ptbv Ratio	4.87
Relative Volume	0.68x
Revenue	897,994,471x
SBC By Revenue	6.04x
Share Based Comp	54,252,838
Tax By Revenue	-0.01x
Tr6m	-13.25%
Volume	266,600
Z Score	3.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/2509 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/2509 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2509?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.1%

Share of float held by funds and institutions

Insider ownership

+4.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.9%

Negative means the company is buying back shares.

Technical

HKG/2509 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.6

Neutral momentum band

Price vs 200-day MA

-23.8%

50/200-day relationship not available

Beta (5Y)

1.44

More volatile than the market

Sharpe ratio

0.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2509

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2509 stock rating?

hkg/2509 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2509 analysis?

The full report lives at /stocks/hkg/2509/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2509?

The latest report frames hkg/2509 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2509 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.